{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["FGFBP1", "Fgf signaling", "apoptosis", "flavonoid", "inhibitor", "lymphoma"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "39005939", "DateRevised": {"Year": "2024", "Month": "07", "Day": "16"}, "Article": {"Language": ["eng"], "ELocationID": ["1408389", "10.3389/fphar.2024.1408389"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "28"}], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2024"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "B4 suppresses lymphoma progression by inhibiting fibroblast growth factor binding protein 1 through intrinsic apoptosis.", "Pagination": {"StartPage": "1408389", "MedlinePgn": "1408389"}, "Abstract": {"AbstractText": ["Lymphoma positions as the fifth most common cancer, in the world, reporting remarkable deaths every year. Several promising strategies to counter this disease recently include utilizing small molecules that specifically target the lymphoma cellular proteins to overwhelm its progression. FGFBP1 is a soluble intracellular protein that progresses cancer cell proliferation and is upregulated in several cancers. Therefore, inhibiting FGFBP1 could significantly slow down lymphoma progression through triggering apoptosis. Thus, in this study, a flavonoid B4, isolated from <i>Cajanus cajan</i>, has been investigated for its effects of B4 on lymphoma, specifically as an FGFBP1 inhibitor. B4 could selectively hinder the growth of lymphoma cells by inducing caspase-dependent intrinsic apoptosis through G<sub>1</sub>/S transition phase cell cycle arrest. RNA sequencing analysis revealed that B4 regulates the genes involved in B-cell proliferation and DNA replication by inhibiting FGFBP1 <i>in vitro</i>. B4 increases the survival rate of lymphoma mice. B4 also represses the growth of patient-derived primary lymphoma cells through FGFBP1 inhibition. Drug affinity responsive target stability experimentations authorize that B4 powerfully binds to FGFBP1. The overexpression of FGFBP1 raises the pharmacological sensitivity of B4, supplementing its specific action on lymphoma cells. This study pioneers the estimation of B4 as a possible anticancer agent for lymphoma treatment. These outcomes highlight its selective inhibitory effects on lymphoma cell growth by downregulating FGFBP1 expression through intrinsic apoptosis, causing mitochondrial and DNA damage, ultimately leading to the inhibition of lymphoma progression. These suggest B4 may be a novel FGFBP1 inhibitor for the lymphoma treatment."], "CopyrightInformation": "Copyright \u00a9 2024 Varier, Dan, Li, Liu, Jiang, Linghu, Li, Ben-David, Zhang, Xiao, Gajendran and Shen."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Varier", "ForeName": "Krishnapriya M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Dan", "ForeName": "Gou", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Li", "ForeName": "Xiaolong", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Jiang", "ForeName": "Fei", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Linghu", "ForeName": "Ke-Gang", "Initials": "KG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Li", "ForeName": "Yanmei", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhang", "ForeName": "Nenling", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Xiao", "ForeName": "Chaoda", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Shen", "ForeName": "Xiangchun", "Initials": "X"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ashidi J. S., Houghton P. J., Hylands S., Efferth T. (2010). Ethnobotanical survey and cytotoxicity testing of plants of South-western Nigeria used to treat cancer, with isolation of cytotoxic constituents from Cajanus cajan Millsp. Leaves. J. Ethnopharmacol. 128 (2), 501\u2013512. 10.1016/j.jep.2010.01.009", "ArticleIdList": ["10.1016/j.jep.2010.01.009", "20064598"]}, {"Citation": "Chen H. C., Eling N., Martinez-Jimenez C. P., O'Brien L. M., Carbonaro V., Marioni J. C., et al. (2019). IL-7-dependent compositional changes within the \u03b3\u03b4 T cell pool in lymph nodes during ageing lead to an unbalanced anti-tumour response. EMBO Rep. 20 (8), e47379. 10.15252/embr.201847379", "ArticleIdList": ["10.15252/embr.201847379", "PMC6680116", "31283095"]}, {"Citation": "Egnatchik R. A., Brittain E. L., Shah A. T., Fares W. H., Ford H. J., Monahan K., et al. (2017). Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension. Pul. Circ. 7 (1), 186\u2013199. 10.1086/690236", "ArticleIdList": ["10.1086/690236", "PMC5448547", "28680578"]}, {"Citation": "Gajendran B., Varier K. M., Liu W., Wang C., Sample K. M., Zacksenhaus E., et al. (2020). A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3. Comm. Bio. 3 (1), 732. 10.1038/s42003-020-01458-3", "ArticleIdList": ["10.1038/s42003-020-01458-3", "PMC7713351", "33273692"]}, {"Citation": "Groff B. D., Kinman A. W. L., Woodroof J. F., Pompano R. R. (2019). Immunofluorescence staining of live lymph node tissue slices. imm 464, 119\u2013125. 10.1016/j.jim.2018.10.010", "ArticleIdList": ["10.1016/j.jim.2018.10.010", "PMC6322934", "30343099"]}, {"Citation": "Hu G. J., Varier K. M., Gajendran B., Jiang F., Liu W., et al. (2022). UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression. Cell death Dis. 8 (1), 448. 10.1038/s41420-022-01244-6", "ArticleIdList": ["10.1038/s41420-022-01244-6", "PMC9637110", "36335089"]}, {"Citation": "Kim H. R., Mun Y., Lee K. S., Park Y. J., Park J. S., Park J. H., et al. (2018). T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nat. Comm. 9 (1), 3630. 10.1038/s41467-018-06090-8", "ArticleIdList": ["10.1038/s41467-018-06090-8", "PMC6128830", "30194420"]}, {"Citation": "Lei X. Y., Liu S. H., Zhao Y. X., Guo M. J., Tao L., Shen X. C., et al. (2022). Lignans and flavonoids from Cajanus cajan (L.) Millsp. and their \u03b1-Glucosidase inhibitory activities. Chem. Biodivers. 19 (11), e202200414. 10.1002/cbdv.202200414", "ArticleIdList": ["10.1002/cbdv.202200414", "36200645"]}, {"Citation": "Liu L., Lim M. A., Jung S. N., Oh C., Won H. R., Jin Y. L., et al. (2021). The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer. Phytomed 92, 153758. 10.1016/j.phymed.2021.153758", "ArticleIdList": ["10.1016/j.phymed.2021.153758", "34592487"]}, {"Citation": "Ma J., Pan Z., Du H., Chen X., Zhu X., Hao W., et al. (2023). Luteolin induces apoptosis by impairing mitochondrial function and targeting the intrinsic apoptosis pathway in gastric cancer cells. Onco. Let. 26 (2), 327. 10.3892/ol.2023.13913", "ArticleIdList": ["10.3892/ol.2023.13913", "PMC10320424", "37415631"]}, {"Citation": "Milano A. F. (2023). Non-hodgkin lymphoma - nodal and extranodal: 20-year comparative mortality, survival and biologic behavior analysis by age, sex, race, stage, cell morphology/histology, cohort entry time-period and disease duration: a systematic review of 384,651 total nhl cases including 261,144 nodal and 123,507 extranodal cases for diagnosis years 1975-2016: (SEER*Stat 8.3.6). J. Insur Med. 50 (1), 1\u201335. 10.17849/insm-50-1-1-35.1", "ArticleIdList": ["10.17849/insm-50-1-1-35.1", "37725503"]}, {"Citation": "Ni S., Chen X., Yu Q., Xu Y., Hu Z., Zhang J., et al. (2020). Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth. Euro J. Med. Chem. 185, 111848. 10.1016/j.ejmech.2019.111848", "ArticleIdList": ["10.1016/j.ejmech.2019.111848", "31732254"]}, {"Citation": "Qiao D., Xing J., Duan Y., Wang S., Yao G., Zhang S., et al. (2022). The molecular mechanism of baicalein repressing progression of gastric cancer mediating miR-7/FAK/AKT signaling pathway. Phytomed 100, 154046. 10.1016/j.phymed.2022.154046", "ArticleIdList": ["10.1016/j.phymed.2022.154046", "35306368"]}, {"Citation": "Qiu T., Hou L., Zhao L., Wang X., Zhou Z., Yang C., et al. (2023). SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1. J. Biol. Chem. 299 (11), 105351. 10.1016/j.jbc.2023.105351", "ArticleIdList": ["10.1016/j.jbc.2023.105351", "PMC10641673", "37838174"]}, {"Citation": "Sarosiek K. A., Wood K. C. (2023). Endogenous and imposed determinants of apoptotic vulnerabilities in cancer. Trend. Can. 9 (2), 96\u2013110. 10.1016/j.trecan.2022.10.004", "ArticleIdList": ["10.1016/j.trecan.2022.10.004", "PMC10241480", "37284233"]}, {"Citation": "Schulze D., Plohmann P., H\u00f6bel S., Aigner A. (2011). Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma. Mole Can. 10, 144. 10.1186/1476-4598-10-144", "ArticleIdList": ["10.1186/1476-4598-10-144", "PMC3281803", "22111880"]}, {"Citation": "Shaked Y., Cervi D., Neuman M., Chen L., Klement G., Michaud C. R., et al. (2005). The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cells. Blood 105 (11), 4500\u20134507. 10.1182/blood-2004-08-3210", "ArticleIdList": ["10.1182/blood-2004-08-3210", "PMC1895028", "15701719"]}, {"Citation": "Syrykh C., Abreu A., Amara N., Siegfried A., Maisongrosse V., Frenois F. X., et al. (2020). Accurate diagnosis of lymphoma on whole-slide histopathology images using deep learning. NPJ Digit. Med. 3, 63. 10.1038/s41746-020-0272-0", "ArticleIdList": ["10.1038/s41746-020-0272-0", "PMC7195401", "32377574"]}, {"Citation": "Tassi E., Lai E. Y., Li L., Solis G., Chen Y., Kietzman W. E., et al. (2018). Blood pressure control by a secreted FGFBP1 (fibroblast growth factor-binding protein). Hypertens. Dallas, Tex. 71 (1), 160\u2013167. 10.1161/HYPERTENSIONAHA.117.10268", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.117.10268", "PMC5730494", "29158353"]}, {"Citation": "Tassi E., McDonnell K., Gibby K. A., Tilan J. U., Kim S. E., Kodack D. P., et al. (2011). Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing. Am. Path. 179 (5), 2220\u20132232. 10.1016/j.ajpath.2011.07.043", "ArticleIdList": ["10.1016/j.ajpath.2011.07.043", "PMC3204016", "21945411"]}, {"Citation": "Tassi E., Wellstein A. (2006). The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma. Semi onco 33 (6 Suppl. 11), S50\u2013S56. 10.1053/j.seminoncol.2006.10.014", "ArticleIdList": ["10.1053/j.seminoncol.2006.10.014", "PMC1781498", "17178288"]}, {"Citation": "Thorne N., Auld D. S., Inglese J. (2010). Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Cur Opin. Chem. Biol. 14 (3), 315\u2013324. 10.1016/j.cbpa.2010.03.020", "ArticleIdList": ["10.1016/j.cbpa.2010.03.020", "PMC2878863", "20417149"]}, {"Citation": "Tomaszewski M., Charchar F. J., Nelson C. P., Barnes T., Denniff M., Kaiser M., et al. (2011). Pathway analysis shows association between FGFBP1 and hypertension. J Ame Soc Neph JASN 22 (5), 947\u2013955. 10.1681/ASN.2010080829", "ArticleIdList": ["10.1681/ASN.2010080829", "PMC3083316", "21436287"]}, {"Citation": "Varier K. M., Dan G., Liu W., Wu G., Xiao C., Lei H., et al. (2022). Stilbene B10 induces apoptosis and tumor suppression in lymphoid Raji cells by BTK-mediated regulation of the KRAS/HDAC1/EP300/PEBP1 axis. Biomed. Pharmacother. 156, 113887. 10.1016/j.biopha.2022.113887", "ArticleIdList": ["10.1016/j.biopha.2022.113887", "36274467"]}, {"Citation": "Wang C., Sample K. M., Gajendran B., Kapranov P., Liu W., Hu A., et al. (2021a). FLI1 induces megakaryopoiesis gene expression through WAS/WIP-dependent and independent mechanisms; implications for wiskott-aldrich syndrome. Fron imm 12, 607836. 10.3389/fimmu.2021.607836", "ArticleIdList": ["10.3389/fimmu.2021.607836", "PMC7953068", "33717090"]}, {"Citation": "Wang F., Luo M., Qu H., Cheng Y. (2021b). BAP1 promotes viability and migration of ECA109 cells through KLF5/CyclinD1/FGF-BP1. FEBS Open Bio 11 (5), 1497\u20131503. 10.1002/2211-5463.13105", "ArticleIdList": ["10.1002/2211-5463.13105", "PMC8091813", "33529461"]}, {"Citation": "Xu X., Fan R., Ruan Y., Xu M., He J., Cao M., et al. (2021). Inhibition of PLC\u03b21 signaling pathway regulates methamphetamine self-administration and neurotoxicity in rats. Food Chem. toxi 149 (2021), 111970. 10.1016/j.fct.2021.111970", "ArticleIdList": ["10.1016/j.fct.2021.111970", "33421459"]}, {"Citation": "Zhang L., Li L., Chen X., Yuan S., Xu T., Zhao W., et al. (2023). Evodiamine inhibits ESCC by inducing M-phase cell-cycle arrest via CUL4A/p53/p21 axis and activating noxa-dependent intrinsic and DR4-dependent extrinsic apoptosis. Phytomedicine 108, 154493. 10.1016/j.phymed.2022.154493", "ArticleIdList": ["10.1016/j.phymed.2022.154493", "36265256"]}, {"Citation": "Zhang Z., Qin Y., Ji S., Xu W., Liu M., Hu Q., et al. (2021). FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer. Acta Biochim. Biophys. Sin. 53 (8), 997\u20131008. 10.1093/abbs/gmab074", "ArticleIdList": ["10.1093/abbs/gmab074", "34117747"]}, {"Citation": "Zhou J., Zhao R., Zhou H., Yang S., Tao F., Xie Y., et al. (2023). A novel benzothiazole derivative induces apoptosis via the mitochondrial intrinsic pathway producing antitumor activity in colorectal cancer. Fron. Pharm. 14, 1196158. 10.3389/fphar.2023.1196158", "ArticleIdList": ["10.3389/fphar.2023.1196158", "PMC10242024", "37288115"]}, {"Citation": "Zhu X., Liu D., Li G., Zhi M., Sun J., Qi L., et al. (2022). Exosomal miR-140-3p and miR-143-3p from TGF-\u03b21-treated pancreatic stellate cells target BCL2 mRNA to increase \u03b2-cell apoptosis. Mole Cell. endo 551, 111653. 10.1016/j.mce.2022.111653", "ArticleIdList": ["10.1016/j.mce.2022.111653", "35513284"]}, {"Citation": "Zuo W., Zhu Y., Liu Z., Xia Y., Xu Y., Peng C., et al. (2021). BRD4 inhibition sensitizes aggressive non-Hodgkin lymphomas to PI3K\u03b4 inhibitors by suppressing PI3K reactivation and c-MYC expression. Am. J. Cancer Res. 11 (1), 215\u2013235. PMC7840716.", "ArticleIdList": ["PMC7840716", "33520370"]}]}], "History": [{"Year": "2024", "Month": "3", "Day": "28"}, {"Year": "2024", "Month": "5", "Day": "14"}, {"Year": "2024", "Month": "7", "Day": "15", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "7", "Day": "15", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "7", "Day": "15", "Hour": "5", "Minute": "23"}, {"Year": "2024", "Month": "6", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["39005939", "PMC11239434", "10.3389/fphar.2024.1408389", "1408389"]}}]}